These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Myelodysplastic syndromes: preleukemic or early leukemic conditions? Dörmer P Haematol Blood Transfus; 1990; 33():3-7. PubMed ID: 2323634 [No Abstract] [Full Text] [Related]
26. Preleukemic syndrome in a dog. Couto CG; Kallet AJ J Am Vet Med Assoc; 1984 Jun; 184(11):1389-92. PubMed ID: 6735862 [No Abstract] [Full Text] [Related]
27. Preleukemic states--its current progress in diagnosis and treatment. Uchino H Jpn J Med; 1989; 28(4):445. PubMed ID: 2810918 [No Abstract] [Full Text] [Related]
28. [Definition, diagnosis and treatment of preleukemic syndrome]. Yamagishi M; Yoshida Y; Uchino H Nihon Rinsho; 1989 May; 47(5):1185-9. PubMed ID: 2664276 [No Abstract] [Full Text] [Related]
29. Progressive preleukemia presenting amegakaryocytic thrombocytopenic purpura: association of the 5q- syndrome with a decreased megakaryocytic colony formation and a defective production of Meg-CSF. Geissler D; Thaler J; Konwalinka G; Peschel C Leuk Res; 1987; 11(8):731-7. PubMed ID: 3498097 [TBL] [Abstract][Full Text] [Related]
30. Secondary hematological changes mimicking the preleukemic syndrome. Report of two cases. Hast R; Beran M Acta Med Scand; 1981; 209(6):521-3. PubMed ID: 7257871 [TBL] [Abstract][Full Text] [Related]
31. Preleukemia and urticaria pigmentosa followed by acute myelomonoblastic leukemia. Vilter RW; Wiltse D Arch Intern Med; 1985 Feb; 145(2):349-52. PubMed ID: 3856421 [TBL] [Abstract][Full Text] [Related]
35. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M Leukemia; 1994 May; 8(5):844-9. PubMed ID: 8182940 [TBL] [Abstract][Full Text] [Related]
36. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Pedersen-Bjergaard J; Philip P; Pedersen NT; Hou-Jensen K; Svejgaard A; Jensen G; Nissen NI Cancer; 1984 Aug; 54(3):452-62. PubMed ID: 6733676 [TBL] [Abstract][Full Text] [Related]
37. [Cholinergic mechanisms in the development of cytopenia as a preleukemic syndrome (the problems of pathogenesis, diagnosis and therapy)]. Savina LS; Martynova VA; Savin AG Voen Med Zh; 1989 Jul; (7):38-42. PubMed ID: 2683369 [No Abstract] [Full Text] [Related]
38. Preleukemia in children. Blank J; Lange B J Pediatr; 1981 Apr; 98(4):565-8. PubMed ID: 7205482 [TBL] [Abstract][Full Text] [Related]
39. Nuclear bridging of erythroblasts in acquired dyserythropoiesis: an early and transient preleukemic marker. Bethlenfalvay NC; Phaure TA; Phyliky RL; Bowman RP Am J Hematol; 1986 Mar; 21(3):315-22. PubMed ID: 3946411 [TBL] [Abstract][Full Text] [Related]
40. [Hematologic and cytogenetic study of 7 cases of preleukemic state or acute leukemia following the treatment of a first malignancy]. Smadja N; Krulik M; Audebert AA; Brissaud P; Debray J Sem Hop; 1983 Jun; 59(23):1729-35. PubMed ID: 6308798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]